Imaginatik PLC Trading Update (4127X)

TIDMIMTK

RNS Number : 4127X

Imaginatik PLC

07 February 2013

7 February 2013

Imaginatik Plc

("Imaginatik" or the "Company")

Trading Update

Imaginatik plc (AIM: IMTK.L), the world's first full service innovation provider offering a range of technology products and consultancy, today announces an update on trading for the year ending 31 March 2013.

While good progress has been made this year on signing new customers and up-selling to existing customers, three long-standing customers which were expected to renew in the second half of the year have opted not to do so, due to budgetary constraints. These three contracts were expected to generate licence fee income of approximately GBP0.35m to be recognized in the results for the current financial year.

Each of these contracts was based on the Company's old 'technology only' model with no consultancy support, a model which Imaginatik is making efforts to move away from in order to increase both the effectiveness of the innovation programmes and the stickiness of the customer base.

In addition to the loss of these contracts, there remains some uncertainty over the timing of the signatures on some potential new contracts. The timing of contract signatures may impact the level of loss for the year and the Company's working capital requirements.

Therefore, the Board believes both revenues and operating losses are likely to be below market expectations.

In light of the above, the Company is considering the possibility of seeking shareholder approval of the cancellation of trading in the Company shares on AIM ("Admission"). The Directors of the Company consider that the costs associated with maintaining Admission may not be currently justified by the benefits given the low liquidity in the Company's shares and the current difficulties in sourcing equity financing for smaller companies in the public markets. A further announcement will be made in due course.

Matt Cooper, Executive Chairman of Imaginatik, commented: "The number of new blue-chip companies turning to Imaginatik as their innovation partner of choice is a fantastic endorsement of our business. However, our return to revenue growth and profitability has not been as swift as we would hope. We do however continue to firmly believe the long-term prospects for the Company to be significant. The Board will now commence a review as to whether maintaining the AIM listing is in the best interests of the Company's shareholders."

For further information please contact:

 
 Imaginatik plc                            Tel: 020 7917 
                                            2975 
 Matt Cooper, Executive Chairman / Shawn 
  Taylor, CFO 
 
 Northland Capital Partners Limited        Tel: 020 7796 
                                            8800 
 Edward Hutton / William Vandyk 
 
 Newgate Threadneedle                      Tel: 020 7653 
                                            9850 
 Caroline Evans-Jones / Hilary Millar

About Imaginatik

Imaginatik provides a range of Innovation solutions comprised of consultancy, enterprise software and program management to deliver innovation results to companies such as The World Bank, The Chubb Group of Insurance Companies, State Farm, Exxon Mobil, Pfizer, Goodyear, Paccar and Cargill. Few companies possess the internal capability to consistently generate fresh ideas, identify those worth pursuing and reliably transform them into real, value-enhancing assets. Imaginatik's mission is to help these companies build sustainable innovation competencies.

Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and is a World Economic Forum Technology Pioneer with offices in Boston, MA, and Winchester, UK. For more information visit www.imaginatik.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

TSTUGUPPPUPWGCM

Abal (LSE:ABAL)
Historical Stock Chart
From Jun 2024 to Jul 2024